UNSPSC 51202505: Procodazole sodium

This classification denotes a biological response modifier C10H9N2O2.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9A8201NX4I, chemically known as 1h-benzimidazole-2-propanoic acid, monosodium salt, but more generally known as procodazole sodium, which bears US NIH Compound Identifier 72710717. Most nations, for tariff and trade purposes, schedule procodazole sodium under HS 29339990 and SITC 51577. As of Q4 2014, PROCODAZOLE SODIUM remains US FDA's Preferred Term for this commodity. SMILES: C1CCC2C(C1)[NH]C(N2)CCC(=O)[O-].[NA+].

UNSPSC 51202505 Procodazole sodium is a Commodity code under which state and local governments procure pharmaceuticals, over-the-counter medical products, and drug-management supplies to support public health, emergency response, and employee wellness programs. Recent opportunities show procurement spanning naloxone and drug deactivation systems for community health initiatives, generic pharmaceuticals and OTC products distributed through cooperative purchasing agreements, medical and first aid supplies for emergency response divisions, and direct-to-manufacturer prescription programs to optimize pharmacy benefit management. Issuing bodies include county health departments (Seminole County), city fire and rescue divisions (Tampa Fire Department), state health and human services commissions (Texas HHS), and multistate cooperative purchasing alliances (MMCAP). The code draws activity from both standalone county and municipal procurements and from consolidated state and regional cooperative purchasing vehicles that aggregate demand across multiple jurisdictions.

Geographic concentration appears in Florida, Texas, and Minnesota, with MMCAP's multistate cooperative extending reach to Oregon and other participating states. Representative recent opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries (due July 26, 2026, though the posted date of Jun 30, 2026 appears inconsistent with the listed due date of Jul 26, 2023); the City of Tampa's IFB for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, estimated at $700,000.00 with a response deadline of Mar 13, 2026 and designated as a sheltered Small Local Business Enterprise (SLBE) opportunity offering a 5% bid discount; and MMCAP's RFP to establish multiple contracts for generic pharmaceuticals and OTC products with proposals due Mar 26, 2026 and awards effective July 1, 2026. The Texas HHS Commission's RFI posted in April 2026 represents exploratory market research for a direct-to-manufacturer prescription program rather than a formal competitive procurement. Set-asides and preferences appear in select opportunities—the Tampa procurement specifically targets SLBEs—though not uniformly across the code.